Compare Sinergi Multi Lestarindo Tbk. (SMLE) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinergi Multi Lestarindo Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Sinergi Multi Lestarindo Tbk. trades at Rp177 (market cap 414.41B, 19.89M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 30.4× Sinergi Multi Lestarindo Tbk.'s market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (19.89M versus 235.2K). Which is the better fit depends on your goals.
| SMLE | TSPC | |
|---|---|---|
Market Cap | 414.41B | 12.58T |
Volume | 19.89M | 235.2K |
Lot | 198.86K | 2.35K |
Turnover | 3.5B | 649.94M |
Average Price | 176.21 | 2,763.37 |
Value | 3.5B | 649.94M |
Indicative Equilibrium Price | 184 | 2,780 |
Indicative Equilibrium Volume | 1.71K | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinergi Multi Lestarindo Tbk.
PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
